Scinai Immunotherapeutics Depreciation & Amortization Growth & History (SCNI)

Scinai Immunotherapeutics's depreciation and amortization was $1.4M for fiscal 2025.

View full Scinai Immunotherapeutics company overview

Scinai Immunotherapeutics annual depreciation and amortization history

Scinai Immunotherapeutics annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31$1.4M−$228,000−13.83%
20242024-12-31$1.6M$1.1M+220.82%
20232023-12-31$514,000−$48,000−8.54%
20222022-12-31$562,000$91,000+19.32%
20212021-12-31$471,000
20172017-12-31$127,000

Scinai Immunotherapeutics depreciation and amortization trends

Between the periods ended 2017-12-31 and 2025-12-31, Scinai Immunotherapeutics's depreciation and amortization increased from $127,000 to $1.4M, a change of $1.3M. The latest reported quarter, Q2 2026, shows $586,000.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Scinai Immunotherapeutics source filings ↗

Community posts

It’s quiet here.

No posts about SCNI yet. Start the conversation.

Write the first post